OncoVentEnters into a License and Distribution Agreement with Orient EuroPharma
28 Mar 2023 //
PR NEWSWIRE
Orient`s Generic Ezetimibe Receives Approval in the U.S.
13 Sep 2022 //
FDA
Orient Pharma`s Generic Pitavastatin Calcium Receives Approval In US
03 Feb 2017 //
FDA